The report provides a detailed analysis essential for establishing a rilmenidine production plant. It encompasses all critical aspects necessary for rilmenidine production, including the cost of rilmenidine production, rilmenidine plant cost, rilmenidine production costs, and the overall rilmenidine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a rilmenidine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Rilmenidine is a prescription drug that finds important applications in managing high blood pressure. It is primarily utilised as a medication for the treatment of high blood pressure, which helps in managing hypertension in patients. It works by targeting certain receptors in the brain that help reduce nerve signals responsible for tightening blood vessels, which leads to lower blood pressure levels. It is commonly formulated into oral tablets and is often prescribed for long-term cardiovascular care. It is often used for its ability to lower blood pressure without causing excessive sedation or slowing of the heart. In addition, rilmenidine is also studied in clinical research for its potential role in improving kidney function and supporting metabolic health in certain cases. It has also been explored for its potential in managing metabolic disorders and certain age-related health conditions.
The demand for rilmenidine is predominantly driven by its application as a medication for patients with mild to moderate hypertension, especially in long-term treatment plans, which supports its market growth. Its application as an effective antihypertensive drug in modern hypertension treatment and in managing metabolic disorders further contributes to its demand in the medical and healthcare sectors. Its demand as an oral drug among patients who require blood pressure control with fewer side effects compared to some other antihypertensive drugs significantly drives its market growth.
Its application in improving blood vessel function and supporting overall heart health further contributes to its growing adoption in modern hypertension care. Furthermore, industrial rilmenidine procurement practices are defined on the basis of several factors, including the cost and availability of raw materials, strict regulatory compliance, and quality standards in pharmaceutical production. Moreover, advancements in drug formulation technologies, supplier reliability, sustainability measures, and efficient distribution networks largely impact its procurement strategies and overall market trends.
Raw Material for Rilmenidine Production
According to the rilmenidine production plant project report, the major raw materials for rilmenidine production include 2-ethoxyoxazoline, bicyclopropylmethylamine, cyclohexane, and phosphoric acid.
Production Process of Rilmenidine
The extensive rilmenidine production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of rilmenidine phosphate begins with the reaction of 2-ethoxyoxazoline and bicyclopropylmethylamine in toluene under reflux to form the desired intermediate compound. After the reaction, the mixture is cooled and washed with sodium bicarbonate solution, saline, and water to remove impurities. Further, the organic layer is dried, filtered, and concentrated to obtain the crude product, which is then purified by recrystallisation using cyclohexane to produce a high-purity white solid. Then, the purified rilmenidine is combined with phosphoric acid to form its stable phosphate salt, rilmenidine phosphate, as the final product.
Rilmenidine is an oxazoline compound with antihypertensive properties. It appears as a white to off-white solid powder. The molecular formula of the compound is C10H16N2O, and its molar mass is 180.25 g/mol. It has a density of approximately 1.45 g/cm³, and its melting point ranges from 106 degree Celsius to 107 degree Celsius. The boiling point of the compound is approximately 355.5 degree Celsius, and its flash point is around 431.1 degree Celsius. The compound is soluble in dimethyl sulfoxide (DMSO), and its phosphate salt form is freely soluble in water. It is marketed under brand names such as Albarel, Hyperium, Iterium, and Tenaxum. Side effects are generally rare and transient at therapeutic doses and may include drowsiness, dryness of the mouth, asthenia, palpitations, and fatigue. It is recommended to store the compound at -20 degree Celsius. The compound is contraindicated in patients with severe depression and severe kidney failure, and its use should be avoided during pregnancy and lactation.